<!DOCTYPE html>
<html lang="en" data-theme="midnight">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>Radiogenomic Analysis on Glioblastoma (Lesion Segmentation and Subtype Classification) | Jude Research Portfolio</title><!-- Begin Jekyll SEO tag v2.8.0 -->
<title>Radiogenomic Analysis on Glioblastoma (Lesion Segmentation and Subtype Classification) | Jude Research Portfolio</title>
<meta name="generator" content="Jekyll v4.4.1" />
<meta property="og:title" content="Radiogenomic Analysis on Glioblastoma (Lesion Segmentation and Subtype Classification)" />
<meta property="og:locale" content="en_US" />
<meta name="description" content="This project targets radiogenomics analysis for glioblastoma (GBM). The end-to-end pipeline includes:" />
<meta property="og:description" content="This project targets radiogenomics analysis for glioblastoma (GBM). The end-to-end pipeline includes:" />
<link rel="canonical" href="http://localhost:4000/projects/radiogenomics-gbm/" />
<meta property="og:url" content="http://localhost:4000/projects/radiogenomics-gbm/" />
<meta property="og:site_name" content="Jude Research Portfolio" />
<meta property="og:type" content="article" />
<meta property="article:published_time" content="2025-11-19T08:56:50+00:00" />
<meta name="twitter:card" content="summary" />
<meta property="twitter:title" content="Radiogenomic Analysis on Glioblastoma (Lesion Segmentation and Subtype Classification)" />
<script type="application/ld+json">
{"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2025-11-19T08:56:50+00:00","datePublished":"2025-11-19T08:56:50+00:00","description":"This project targets radiogenomics analysis for glioblastoma (GBM). The end-to-end pipeline includes:","headline":"Radiogenomic Analysis on Glioblastoma (Lesion Segmentation and Subtype Classification)","mainEntityOfPage":{"@type":"WebPage","@id":"http://localhost:4000/projects/radiogenomics-gbm/"},"url":"http://localhost:4000/projects/radiogenomics-gbm/"}</script>
<!-- End Jekyll SEO tag -->
<link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="/assets/css/main.css?v=1763542610" />
  </head>
  <body>
    <div id="spotlight" aria-hidden="true"></div>
    <div id="scroll-progress"></div>
    <div class="container layout-two-col" data-layout="project">
      <aside class="sidebar">
        
          <div class="sidebar-inner">
            <p class="back-cta reveal"><a href="/#projects" class="back-link">Back</a></p>
            <div class="detail-card reveal">
              <h3>Overview</h3>
              <ul class="detail-meta">
                <li class="reveal"><span class="k">Duration</span> 2021.09 - 2022.05</li>
                <li class="reveal"><span class="k">Tags</span> Medical Imaging, Segmentation, Radiomics, GBM, U-Net</li>
              </ul>
            </div>
            
          </div>
        
      </aside>
      <main class="content">
        <article class="project">
  <header class="reveal">
    <h1 class="reveal">Radiogenomic Analysis on Glioblastoma (Lesion Segmentation and Subtype Classification)</h1>
    <p class="project-meta reveal"><span>2021.09 - 2022.05</span><span> · Medical Imaging, Segmentation, Radiomics, GBM, U-Net</span></p>
  </header>
  <section class="project-content">
    <div class="reveal"><p>This project targets radiogenomics analysis for glioblastoma (GBM). The end-to-end pipeline includes:</p>

<p>1) Lesion segmentation on MRI using U‑Net variants to obtain precise ROIs (lesion Regions of Interest)<br />
2) Radiomics feature extraction on lesion ROIs (tumor regions) with feature engineering<br />
3) GBM subtype classification (e.g., MLP) with evaluation and visualization</p>

<h3 id="objective--contributions">Objective &amp; Contributions</h3>

<ul>
  <li>Objective: anticipate GBM molecular subtypes from routine MRI by linking precise lesion segmentation with radiomics‑based signatures.</li>
  <li>Contributions: a robust end‑to‑end pipeline (segmentation → radiomics → subtype), careful lesion ROI definition that stabilizes radiomic features, and interpretability via mutual information between features and gene expression.</li>
</ul>

<p>In clinic, MRI is routine while molecular assays can be costly or delayed. I asked a simple question: can we anticipate GBM molecular subtypes from what radiologists already see? I built an end‑to‑end pipeline that first teaches a network to delineate the tumor, then turns those ROIs into quantitative radiomic signatures for a lightweight classifier. Along the way, I iterated on data organization, stabilized training on imbalanced modalities, and added analyses that explain which features matter and why.</p>

<h3 id="dataset">Dataset</h3>

<ul>
  <li>Source: Ivy GAP / TCGA‑GBM cohorts, with MRI series T1, T2, FLAIR, and stacked inputs (“Stack”).</li>
  <li>Structure: images/masks organized per patient and series; CSV metadata for slice locations and labels.</li>
  <li>ROIs: manual masks are used to supervise lesion segmentation and to define regions for radiomics extraction.</li>
  <li>Radiomics config: a YAML configuration drives feature extraction (e.g., intensity/texture/shape features).</li>
</ul>

<h3 id="methods">Methods</h3>

<ul>
  <li>
    <p>Typical workflow of radiogenomic studies</p>

    <p><img src="/assets/img/project/radiogenomics-gbm/workflow-radiogenomic.png" alt="Typical workflow of radiogenomic studies" /></p>

    <p>1) Image acquisition<br />
2) Image processing, including noise/artifact reduction, intensity and/or orientation standardization, coregistration of the multiparametric MRI scans<br />
3) ROI definition using manual annotation or automatic segmentation<br />
4) Feature extraction based on human-engineered (conventional radiomics) or deep-learning approaches<br />
5) Data analysis, involving machine/deep-learning methods for feature selection, classification, and cross-validation</p>
  </li>
  <li>Segmentation (U‑Net family)
    <ul>
      <li>Supervised learning with lesion masks; architectures based on U‑Net variants adapted for GBM MRI.</li>
      <li>Robust preprocessing and modality‑aware batching to handle sequence imbalance.</li>
      <li>Outputs include training dynamics and qualitative visualizations for each sequence.</li>
    </ul>
  </li>
  <li>Radiomics Feature Extraction
    <ul>
      <li>Extract quantitative features from lesion ROIs; feature families cover intensity, texture, and shape.</li>
      <li>Post‑processing includes normalization and PCA; we compare both ordering strategies (Normalize→PCA vs. PCA→Normalize).</li>
    </ul>
  </li>
  <li>Subtype Classification
    <ul>
      <li>Train a lightweight MLP on engineered radiomics features to predict GBM molecular subtypes.</li>
      <li>A baseline following prior work (Wang 2017) reaches ~92% accuracy on subtype prediction.</li>
    </ul>
  </li>
  <li>Mutual Information Analysis
    <ul>
      <li>Compute mutual information between radiomics features and gene expression energy to assess relevance and interpretability.</li>
    </ul>
  </li>
</ul>

<h3 id="results">Results</h3>

<ul>
  <li>Segmentation: qualitative examples and training curves demonstrate stable convergence across sequences.</li>
  <li>Classification: repo notes an MLP classifier achieving ~92% accuracy on subtype prediction. ROC/AUC plots are provided for model assessment.</li>
  <li>Analysis: MI results highlight associations between selected radiomics features and gene expression energy, supporting biological plausibility.</li>
</ul>

<h3 id="discussion">Discussion</h3>

<ul>
  <li>ROI quality strongly impacts downstream subtype classification; better lesion delineation improves radiomics stability.</li>
  <li>Feature engineering (normalization/PCA order) affects classifier performance and interpretability; the repo retains both pipelines for comparison.</li>
  <li>Limitations: slice‑based training and cohort size constrain generalization; modality imbalance may bias results.</li>
  <li>Future directions: 3D/2.5D segmentation, multi‑sequence fusion, cross‑cohort validation, and end‑to‑end multi‑task learning (segmentation + subtype).</li>
</ul>

<h3 id="repository">Repository</h3>

<p>Radiogenomics‑GBM (GitHub): https://github.com/PinkR1ver/Radiogenomics-GBM</p>

</div>
  </section>
  </article>



      </main>
    </div>
    <footer class="site-footer">
      <div class="container">
        <p>&copy; 2025 Jude Research Portfolio</p>
      </div>
    </footer>
    
    <button id="back-to-top" aria-label="Back to top">↑</button>
    <script src="/assets/js/main.js?v=1763542610" defer></script>
  </body>
  </html>


